BC
Birchview Capital’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.05M | Sell |
187,800
-75,600
| -29% | -$1.63M | 4.02% | 5 |
|
|
2025
Q1 | $4.38M | Sell |
263,400
-75,000
| -22% | -$1.25M | 3.8% | 3 |
|
|
2024
Q4 | $6.21M | Sell |
338,400
-62,000
| -15% | -$1.14M | 5.05% | 3 |
|
|
2024
Q3 | $6.16M | Buy |
400,400
+150,000
| +60% | +$2.31M | 5.33% | 3 |
|
|
2024
Q2 | $4.07M | Hold |
250,400
| – | – | 3.76% | 7 |
|
|
2024
Q1 | $4.63M | Buy |
250,400
+10,000
| +4% | +$185K | 3.77% | 5 |
|
|
2023
Q4 | $7.53M | Hold |
240,400
| – | – | 5.89% | 4 |
|
|
2023
Q3 | $5.01M | Sell |
240,400
-9,000
| -4% | -$188K | 4.26% | 5 |
|
|
2023
Q2 | $5.97M | Hold |
249,400
| – | – | 4.48% | 5 |
|
|
2023
Q1 | $4.69M | Hold |
249,400
| – | – | 3.68% | 6 |
|
|
2022
Q4 | $3.97M | Hold |
249,400
| – | – | 2.8% | 9 |
|
|
2022
Q3 | $4.08M | Hold |
249,400
| – | – | 2.87% | 6 |
|
|
2022
Q2 | $3.51M | Buy |
249,400
+50,000
| +25% | +$704K | 2.56% | 8 |
|
|
2022
Q1 | $4.83M | Hold |
199,400
| – | – | 3.48% | 5 |
|
|
2021
Q4 | $4.65M | Hold |
199,400
| – | – | 3% | 8 |
|
|
2021
Q3 | $3.31M | Hold |
199,400
| – | – | 2.25% | 10 |
|
|
2021
Q2 | $4.86M | Buy |
199,400
+22,400
| +13% | +$546K | 2.91% | 6 |
|
|
2021
Q1 | $4.57M | Buy |
177,000
+75,000
| +74% | +$1.94M | 2.71% | 6 |
|
|
2020
Q4 | $5.45M | Hold |
102,000
| – | – | 3.14% | 8 |
|
|
2020
Q3 | $4.21M | Buy |
102,000
+9,000
| +10% | +$371K | 2.81% | 6 |
|
|
2020
Q2 | $4.51M | Buy |
93,000
+1,000
| +1% | +$48.5K | 2.72% | 6 |
|
|
2020
Q1 | $3.89M | Buy |
92,000
+78,000
| +557% | +$3.3M | 3.45% | 5 |
|
|
2019
Q4 | $599K | Hold |
14,000
| – | – | 0.44% | 31 |
|
|
2019
Q3 | $504K | Buy |
14,000
+4,000
| +40% | +$144K | 0.34% | 29 |
|
|
2019
Q2 | $267K | Buy |
+10,000
| New | +$267K | 0.16% | 40 |
|